Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Active, not recruiting · NCT04595474 · Registry updated 2026-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, immune system disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, type 1 diabetes mellitus | Active, not recruiting | Not stated | 2026-05-29 | NCT04595474 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Joslin Diabetes Center | 19 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Joslin Diabetes Center | Boston | United States | 37 |